Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Migraine with or without aura fulfilling the International Headache Society (IHS) diagnostic criteria 1.1 and 1.2.1
History of disabling migraine for at least 1 year
Migraine onset before the age of 50 years
History of 3 to 8 migraine attacks per month (\<15 headache days per month) during the past 3 months
MIDAS score ≥11
Able and willing to complete an eDiary to record the details of each migraine attack treated with study drug
Women of child-bearing potential must be using or willing to use a highly effective form of contraception
Agree not to post any personal medical data or information related to the study on any website or social media site until the entire trial has completed
You may not be if
Known hypersensitivity to lasmiditan, or to any excipient of lasmiditan oral tablets
History or evidence of hemorrhagic stroke, epilepsy, or any other condition placing the participant at increased risk of seizures
History of recurrent dizziness and/or vertigo including benign paroxysmal positional vertigo, Meniere's disease, vestibular migraine, and other vestibular disorders
History of diabetes mellitus with complications (diabetic retinopathy, nephropathy, or neuropathy)
History of orthostatic hypotension with syncope
Significant renal or hepatic impairment in the opinion of the investigator or if they meet hepatic monitoring criteria
Participants who, in the investigator's judgment, are actively suicidal and therefore deemed to be at significant risk for suicide
History, within past 12 months, of chronic migraine or other forms of primary or secondary chronic headache disorder (eg, hemicranias continua, medication overuse headache where headache frequency is ≥15 headache days per month)
Use of more than 3 doses per month of either opioids or barbiturates
Initiation of or a change in concomitant medication to reduce the frequency of migraine episodes within 3 months prior to screening
Pregnant or breast-feeding women
History of drug or alcohol abuse/dependence within 1 year prior to screening
Any medical condition or clinical laboratory test which in the judgment of the investigator makes the participant unsuitable for the study
Currently enrolled in any other clinical study involving an investigational product
Relatives of, or staff directly reporting to, the Investigator
